IRWD vs. PBYI: Which Small-Cap Biotech Stock Is the Better Pick? — Positive
IRWD PBYI Zacks Investment Research — November 27, 2025Ironwood and Puma Biotechnology are advancing therapies for gastrointestinal disorders and cancer, respectively. Rising sales of key drugs fuel 2026 prospects.
4 Non-Ferrous Metal Mining Stocks to Consider From a Thriving Industry — Positive
CDE LEU LUNMF SCCO Zacks Investment Research — November 27, 2025The outlook of the Zacks Mining - Non Ferrous industry is promising, backed by strong demand. Stocks like SCCO, LUNMF, CDE and LEU are poised to benefit from this.
Atmos Energy (ATO) Is Up 0.02% in One Week: What You Should Know — Positive
ATO Zacks Investment Research — November 27, 2025Does Atmos Energy (ATO) have what it takes to be a top stock pick for momentum investors? Let's find out.
Banco De Chile (BCH) Is Up 0.66% in One Week: What You Should Know — Positive
BCH Zacks Investment Research — November 27, 2025Does Banco De Chile (BCH) have what it takes to be a top stock pick for momentum investors? Let's find out.
Republic Bancorp (RBCAA) Upgraded to Buy: Here's Why — Positive
RBCAA Zacks Investment Research — November 27, 2025Republic Bancorp (RBCAA) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Are You Looking for a Top Momentum Pick? Why Ventas (VTR) is a Great Choice — Positive
VTR Zacks Investment Research — November 27, 2025Does Ventas (VTR) have what it takes to be a top stock pick for momentum investors? Let's find out.
Topgolf Callaway (MODG) Upgraded to Strong Buy: Here's What You Should Know — Positive
MODG Zacks Investment Research — November 27, 2025Topgolf Callaway (MODG) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
Cardinal Health (CAH) Is Up 2.00% in One Week: What You Should Know — Positive
CAH Zacks Investment Research — November 27, 2025Does Cardinal Health (CAH) have what it takes to be a top stock pick for momentum investors? Let's find out.
What Makes Chime Financial, Inc. (CHYM) a New Buy Stock — Positive
CHYM Zacks Investment Research — November 27, 2025Chime Financial, Inc. (CHYM) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Ensign Group (ENSG) is a Great Momentum Stock: Should You Buy? — Positive
ENSG Zacks Investment Research — November 27, 2025Does Ensign Group (ENSG) have what it takes to be a top stock pick for momentum investors? Let's find out.
What Makes Hyliion (HYLN) a New Buy Stock — Positive
HYLN Zacks Investment Research — November 27, 2025Hyliion (HYLN) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Vipshop (VIPS) Upgraded to Buy: Here's Why — Positive
VIPS Zacks Investment Research — November 27, 2025Vipshop (VIPS) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Guess (GES) Upgraded to Buy: Here's What You Should Know — Positive
GES Zacks Investment Research — November 27, 2025Guess (GES) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Barrick Mining (B) Upgraded to Buy: Here's Why — Positive
B Zacks Investment Research — November 27, 2025Barrick Mining (B) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
All You Need to Know About BigBear.ai (BBAI) Rating Upgrade to Buy — Positive
BBAI Zacks Investment Research — November 27, 2025BigBear.ai (BBAI) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Applied Therapeutics (APLT) Upgraded to Buy: Here's Why — Positive
APLT Zacks Investment Research — November 27, 2025Applied Therapeutics (APLT) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Luminar Technologies (LAZR) Upgraded to Buy: What Does It Mean for the Stock? — Positive
LAZR Zacks Investment Research — November 27, 2025Luminar Technologies (LAZR) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Looking for an extra serving of A.I. insights this Thanksgiving holiday?
Novo Nordisk or Pfizer: Which Healthcare Giant Is the Better Bet? — Neutral
NVO PFE Zacks Investment Research — November 27, 2025PFE's oncology gains and obesity re-entry contrast with NVO's GLP-1 pressures in this in-depth comparison of two healthcare giants.
